Define the business and leadership question
We begin with the organisation's sub-sector, strategy, regulatory context and specific leadership challenge.
Leaders must grow and innovate inside regulatory, quality and ethical boundaries. Judgement and governance therefore matter as much as functional expertise.
The organisation needs leaders who can bridge technical, clinical or scientific depth with market realities, capital allocation and enterprise priorities.
Product development, market access and institutional relationships develop over time. Losing a critical leader can therefore disrupt capability that is difficult to rebuild quickly.
Digital, AI, new care models and changing customer expectations require leaders who can collaborate across science, operations, commercial, technology and people systems.
Technical excellence does not automatically translate into enterprise effectiveness. Future leaders often need greater commercial judgement, stakeholder influence and cross-functional ownership.
Critical knowledge, regulator credibility and specialist networks can take years to rebuild. Boards should distinguish ordinary vacancies from concentrated institutional risk.
New tools can alter research, operations and customer interactions. Leaders need clear governance over decisions, data, risk and adoption.
As organisations scale, informal decision systems can become a risk. Governance should evolve before complexity forces reactive change.
We take on healthcare and life sciences mandates where leadership, governance and transformation expertise can add clear value and where the sector context can be substantiated.
It is a developing practice. We are selective about mandates and focus on leadership, governance and transformation issues where our experience is relevant and demonstrable.
We support leadership strategy, assessment, succession, executive-team effectiveness, selected healthcare executive search and transformation mandates where the sector context is clear and our expertise is relevant.
Yes, at the leadership and organisation level. Pharma leadership, life sciences leadership, succession, executive search and transformation can be within scope; specialist scientific or clinical consulting is not implied.
Yes. Our adjacent consumer-health experience provides relevant context for organisations operating at the intersection of brand, science, growth and trust.
We begin with the business and leadership question, then assess whether our leadership and organisation expertise is the right fit. If a mandate requires specialist clinical or scientific expertise beyond our remit, we do not position Planet Ganges as that provider.
Planet Ganges is a prominent player in Business Transformation, delivering tailored interventions in Organisational Culture, Climate, and Leadership Capability.